Acute and anticipatory emesis in breast cancer patients
A group of 90 breast cancer patients undergoing chemotherapy were assessed prospectively to estimate the prevalence of acute (post-treatment) and anticipatory emesis in the 1990s. For this purpose, two protocols of chemotherapy were analysed separately: cyclophosphamide/methotrexate/5-fluorouracil (CMF) and 5-fluorouracil/doxorubicin/cyclophosphamide (FAC). All patients were treated with antiemetic therapy, which included one corticoid plus ondansetron (in the FAC regimen), or one corticoid plus thiethylperazine (in the CMF regimen). For at least one cycle of chemotherapy 86.1% and 91.7% patients in the FAC protocol presented vomiting and nausea respectively; 11.1% had anticipatory vomiting and 30.6% had anticipatory nausea. In the CMF protocol, 79.6% had post-chemotherapy vomiting and 71.7% had post-chemotherapy nausea associated with at least one cycle. In this group, 7.4% had anticipatory vomiting and 16.6% had anticipatory nausea. A high proportion of patients suffered anticipatory anxiety in both groups (75% in FAC, 74.1% in CMF). The stimuli most frequently associated with the appearance of anticipatory emesis were olfactory stimuli and cognitive stimuli. In summary, as a result of the advances made in antiemetic control during the last decade, the severity of chemotherapy-induced emesis seems to have significantly decreased, but the prevalence of these symptoms along the course of the treatment still remains high.
Key wordsPrevalence Anticipatory emesis Acute emesis Chemotherapy Ondansetron
Unable to display preview. Download preview PDF.
- 1.Aapro MS (1989) Una nueva clase de antieméticos: los antagonistas de la serotonina (5-HT3). Rev Cáncer 3:134–137Google Scholar
- 2.Aapro M, Kirchner V, Terrey JP (1992) Is anticipatory nausea and vomiting a thing of the past? Proc Am Soc Clin Oncol 11:394Google Scholar
- 4.Andrykowski MA (1990) The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis. Psychosom Med 52:258–275Google Scholar
- 12.Haut MW, Beckwith BE, Laurie JA, Klatt N (1991) Postchemotherapy nausea and vomiting in cancer patients receiving outpatient chemotherapy. J Psychosoc Oncol 9:117–130Google Scholar
- 15.Martin M (1992) Myths and realities of antiemetic treatment. Br J Cancer 66 [Suppl 19]:S46-S51Google Scholar
- 17.Martin Jimenez M (1985) Ensayos clínicos sobre la emesis inducida por quimioterapia antineoplásica. Tesis Doctoral, Universidad Complutense de MadridGoogle Scholar
- 18.Morrow GR, Dobkin PL (1988) Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: prevalence, etiology, and behavioral interventions. Clin Psychol Rev 8:517–550Google Scholar
- 19.Roila F, Tonato M, Basurto C, Bracarda S Picciafuoco M, Del Favero A (1989) Factores pronósticos de la emesis inducida por quimioterapia. Rev Cáncer 3:120–124Google Scholar
- 20.Watson M, Marvell C (1992) Anticipatory nausea and vomiting among cancer patients: a review. Psychol Health 6:97–106Google Scholar